机译:由于21-羟化酶缺乏,先天性肾上腺增生的产前地塞米松治疗产前地塞米松治疗的疗效和安全性:系统评价和荟萃分析
Department of EndocrinologyShengli Clinical Medical College of Fujian Medical UniversityFuzhou China;
Department of EndocrinologyShengli Clinical Medical College of Fujian Medical UniversityFuzhou China;
Department of EndocrinologyShengli Clinical Medical College of Fujian Medical UniversityFuzhou China;
Department of EndocrinologyShengli Clinical Medical College of Fujian Medical UniversityFuzhou China;
Department of EndocrinologyShengli Clinical Medical College of Fujian Medical UniversityFuzhou China;
Department of EndocrinologyShengli Clinical Medical College of Fujian Medical UniversityFuzhou China;
Department of EndocrinologyShengli Clinical Medical College of Fujian Medical UniversityFuzhou China;
Department of EndocrinologyShengli Clinical Medical College of Fujian Medical UniversityFuzhou China;
Department of EndocrinologyShengli Clinical Medical College of Fujian Medical UniversityFuzhou China;
Department of EndocrinologyShengli Clinical Medical College of Fujian Medical UniversityFuzhou China;
21‐hydroxylase deficiency; cognition; congenital adrenal hyperplasia; dexamethasone; problem behaviour; temperament; virilization;
机译:由于21-羟化酶缺乏,先天性肾上腺增生的产前地塞米松治疗产前地塞米松治疗的疗效和安全性:系统评价和荟萃分析
机译:产前地塞米松用于预防因21-羟化酶(CYP21A2)缺乏而导致经典先天性肾上腺增生的孕妇的病毒化:系统评价和荟萃分析
机译:先天性肾上腺皮质增生,由于21-羟化酶缺乏症提示为肾上腺偶发性血肿:系统评价和meta分析
机译:先天性肾上腺素增生由于21羟化酶缺乏症的产前诊断和治疗范式
机译:体外冲击波治疗与低水平激光治疗对脑隧道综合征的成人患者疼痛和症状严重程度及函数状况的疗效:系统评价与荟萃分析
机译:Mon-156由于21羟羟化酶缺乏预期肾上腺素增生的后代产前地塞米松治疗产前地塞米松治疗的疗效和安全性
机译:Mon-156由于21羟羟化酶缺乏,预期肾上腺素增生的后代产前地塞米松治疗产前地塞米松治疗的疗效和安全性